| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Erythromycin hydrochloride
CAS:14271-02-4
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
Erythromycin,hydrochloride (8CI,9CI) manufacturers
|
| | Erythromycin,hydrochloride (8CI,9CI) Basic information |
| | Erythromycin,hydrochloride (8CI,9CI) Chemical Properties |
| | Erythromycin,hydrochloride (8CI,9CI) Usage And Synthesis |
| Uses | Erythromycin hydrochloride is a protein synthesis inhibitor with activity against the growth of both Gram-negative and Gram-positive bacteria. Erythromycin hydrochloride is commonly used in biomedicine to inhibit diseases caused by bacterial infections. Erythromycin hydrochloride is also involved in the inhibition of mammalian mRNA splicing. The application range of erythromycin hydrochloride includes respiratory tract infections, skin infections, and other infections caused by sensitive bacteria[1]. | | References | [1] Gribble MJ, et al. Erythromycin. Med Clin North Am. 1982 Jan;66(1):79-89. DOI:10.1016/s0025-7125(16)31443-2
[2] Sarecycline hydrochloride for the treatment of acne vulgaris DOI:10.1358/dot.2019.55.10.3045040
[3] Nakornchai S, et al. Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro. Acta Trop. 2006 Dec;100(3):185-91. Epub 2006 Nov 28. DOI:10.1016/j.actatropica.2006.10.008
[4] Hamada K, et al. Antitumor effect of erythromycin in mice. Chemotherapy. 1995 Jan-Feb. 41(1):59-69. DOI:10.1159/000239325
[5] Katayama Y, et al. Neuroprotective effects of erythromycin on cerebral ischemia reperfusion-injury and cell viability after oxygen-glucose deprivation in cultured neuronal cells. Brain Res. 2014 Nov 7. 1588:159-67. DOI:10.1016/j.brainres.2014.09.016 |
| | Erythromycin,hydrochloride (8CI,9CI) Preparation Products And Raw materials |
|